In Devices, the Market for Mid-Caps Remains Strong
While investors and big company acquirers still seem wary of small device companies, two recent deals--Guidant's acquisition of CardioThoracic Systems and Medtronic's purchase of Xomed, suggest that large device companies will still pay handsomely for companies with established businesses.
You may also be interested in...
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.